Umeå Biotech Incubator (UBI) has been named the only incubator in the Nordic region to once again be granted funding from the prestigious Erling Persson Family Foundation.
UBI is being granted SEK 10 million between 2020-2022 to help researchers commercialise their ideas for the greater benefit of society.
Life science company Inficure Bio attract millions in new funding round.
“Attracting new investment allows us to move faster. We have lots of potential customers and we want to launch new applications for our product”, says Sofia Mayans, CEO of Umeå-based Inficure Bio.
Umeå Biotech Incubator has appointed Lena Karlsson Engman as its new Chairman of the Board. Lena Karlsson Engman, who is a member of the Social Democrats at Umeå City Council and a former researcher at the Swedish Defense Research Agency (FOI) says: “I am very proud and happy”.
Life science company UmanDiagnostics in Umeå has merged with the American listed Quanterix.
”We are incredibly happy. This gives us the opportunity to expand globally”, says Niklas Norgren, CEO.
Umeå Biotech Incubator has been nominated for the prestigious Nordic Startup Awards.
– We are very honored! We strive to be the best incubator in Europe – and the best in the world. This is an acknowledgment that we are on the right path, ”says Jennie Ekbeck, CEO of Umeå Biotech Incubator.
Umeå company Spinchem wins a multi-million deal with the listed Canadian company SNC-Lavalin. Spinchem will supply a so-called Rotating Bed Reactor that will be used to clean process water from the nuclear power industry.
– This is an incredible deal for us. It gives us the opportunity to further develop our product, says Emil Byström, CEO of Spinchem.
Umeå-based life science company Inficure Bio has appointed Lena Söderström, who was previously in charge at stock exchange listed company Senzime, as its new chairman of the board of directors.
Do you have a large network and want to help companies in Västerbotten to find the right competence? Then you are welcome to join our advisory board.
Two representatives of the UBI company Mucocort have published an article in the Stockholm Intellectual Property Law Review on one of the most interesting research discoveries the recent decades – the discovery of CRISPR/Cas9, which can result in a Nobel Prize.
A new report has busted many of the myths surrounding super entrepreneurs, claiming they do not generally have higher IQs than the average person and are not necessarily driven by revenge following a troubled childhood.
The report, compiled by the Stockholm-based Sting incubator together with Umeå Biotech Incubator and researchers from Karolinska Institutet also discovered several important abilities that characterise successful entrepreneurs.
Swedish life science company Omnio has received millions in funding from the Swelife innovation programme to help develop a cure for tooth loss.
“Thanks to these funds from Swelife we can now move forward even faster”, says Omnio’s CEO Patric Stafshede.
Former Olympic biathlete Anders Mannelqvist has been appointed the new CEO of Pro Test Diagnostics, a Life Science company that has developed a unique test kit for blood doping.
Life science industry figurehead Pernilla Abrahamsson has left her position as Product Development Manager at stock market listed Senzime to become Chief Operating Officer (COO) at Lipum, located at the Umeå Biotech Incubator.
Umeå-based life science company Inficure Bio has just won the largest contract in its history.
“It feels incredible! The more large customers we get the greater our credibility becomes. This agreement is a real feather in our cap”, says Sofia Mayans, CEO of Inficure Bio.
Umeå life science company Lipum will participate in one of the world’s largest congresses for rheumatic diseases this June.
“The elite of our industry gathers at this congress once a year and competition is incredibly intense. It’s important to be seen there”, says Einar Pontén, CEO of Lipum.